TYLENOL W Drug Patent Profile
✉ Email this page to a colleague
When do Tylenol W patents expire, and when can generic versions of Tylenol W launch?
Tylenol W is a drug marketed by Ortho Mcneil Pharm and Janssen Pharms and is included in five NDAs.
The generic ingredient in TYLENOL W is acetaminophen; codeine phosphate. There are sixty-six drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the acetaminophen; codeine phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tylenol W
A generic version of TYLENOL W was approved as acetaminophen; codeine phosphate by WES PHARMA INC on June 27th, 2019.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TYLENOL W?
- What are the global sales for TYLENOL W?
- What is Average Wholesale Price for TYLENOL W?
Summary for TYLENOL W
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 5 |
DailyMed Link: | TYLENOL W at DailyMed |